statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules

Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ: FBRX), a clinical-stage biopharmaceutical company focused on autoimmune and autoimmune-related diseases, today announced the issuance of equity...

Forte Biosciences, Inc. Announces First Quarter 2024 Results and Provides Business Update

Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ: FBRX), a clinical-stage biopharmaceutical company focused on autoimmune and autoimmune-related diseases, today announced first quarter 2024...

FY2024 EPS Estimates for Forte Biosciences, Inc. Increased by Analyst (NASDAQ:FBRX)

Forte Biosciences, Inc. (NASDAQ:FBRX  Free Report)  Investment analysts at Chardan Capital boosted their FY2024 EPS estimates for shares of Forte Biosciences in a research note issued...

Forte Biosciences Target of Unusually Large Options Trading (NASDAQ:FBRX)

Forte Biosciences, Inc. (NASDAQ:FBRX  Get Free Report) saw unusually large options trading on Wednesday. Traders purchased 30,205 call options on the stock. This is an increase of 1,663...

Forte Biosciences, Inc. (NASDAQ:FBRX  Get Free Report) saw unusually large options trading on Wednesday. Stock traders purchased 30,205 call options on the stock. This is an increase of...

Forte Biosciences, Inc. Announces 2023 Results and Provides Business Update

Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ: FBRX), a clinical-stage biopharmaceutical company focused on autoimmune and autoimmune-related diseases, today announced its 2023 results and...

Forte Biosciences Sees Unusually High Options Volume (NASDAQ:FBRX)

Forte Biosciences, Inc. (NASDAQ:FBRX  Get Free Report) was the recipient of unusually large options trading on Wednesday. Stock investors purchased 30,205 call options on the company. This is...

Head-To-Head Survey: Forte Biosciences (NASDAQ:FBRX) vs. Unity Biotechnology (NASDAQ:UBX)

Unity Biotechnology (NASDAQ:UBX  Get Free Report) and Forte Biosciences (NASDAQ:FBRX  Get Free Report) are both small-cap medical companies, but which is the superior stock? We will...

Forte Biosciences, Inc. is a biopharmaceutical company, which engages in the provision of dermatology products and services. The firm's lead product includes FB-401, which is a live biotherapeutic for the treatment of inflammatory skin disease, including pediatric and adult patients with atopic dermatitis. The company was founded by Paul A. Wagner in 2017 and is headquartered in Dallas, TX.

Volume	9,874.00
52-Wk High	$1.03
52-Wk Low	$0.38

FBRX Forte Biosciences Inc

About

Feed

News

Sentiment

Fundamentals